Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Emergent BioSolutions Inc (NYSE:EBS)

35.78
Delayed Data
As of Feb 05
 -1.09 / -2.96%
Today’s Change
26.36
Today|||52-Week Range
40.49
-10.57%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues119.5M63.6M126.1M164.9M
 
 
 
 
 
Cost of Goods Sold24.3M9.4M18.5M31.8M
 
 
 
 
 
Depreciation And Amortization8.2M8.5M8.8M8.6M
 
 
 
 
 
 
Operating ExpensesGross Income87.0M45.7M98.8M124.6M
 
 
 
 
 
General Expenses70.9M72.4M78.2M67.7M
 
 
 
 
 
Research And Development39.0M38.7M40.9M33.0M
 
 
 
 
 
Total Operating Expenses103.4M90.4M105.5M108.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income16.1M-26.8M20.6M56.9M
 
 
 
 
 
Extraordinary Credit--0.00808.0K5.9M
 
 
 
Extraordinary Charge---1.6M---9.8M
 
 
 
Interest Expense On Debt1.2M2.3M2.3M2.4M
 
 
 
 
 
Other Expenses29.2M100.0K-497.0K602.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income44.3M-29.8M19.6M52.1M
 
 
 
 
 
Income Taxes-14.2M-8.3M-5.5M-15.1M
 
 
 
 
 
Net Income30.1M-21.5M14.1M36.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS37.6M37.9M38.5M38.8M
 
 
 
 
 
Shares To Calculate EPS Diluted46.4M37.9M47.4M47.8M
 
 
 
 
 
 
Earnings Per ShareEPS$0.66-$0.57$0.32$0.79
 
 
 
 
 
EPS Diluted$0.66-$0.57$0.32$0.79